These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
409 related items for PubMed ID: 4077129
21. Stereospecific 3H-QNB binding to human erythrocyte membranes associated with muscarinic cholinergic receptors. Bering B, Müller WE. J Neural Transm; 1987; 68(1-2):97-111. PubMed ID: 3806087 [Abstract] [Full Text] [Related]
22. Quinuclidinyl benzilate binding in house fly heads and rat brain. Jones SW, Sumikawa K. J Neurochem; 1981 Feb; 36(2):454-9. PubMed ID: 7463072 [Abstract] [Full Text] [Related]
23. Kindled seizures selectively reduce a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat dentate gyrus. Savage DD, McNamara JO. J Pharmacol Exp Ther; 1982 Sep; 222(3):670-3. PubMed ID: 7108770 [Abstract] [Full Text] [Related]
24. Muscarinic cholinergic receptors in developing rat lung. Whitsett JA, Hollinger B. Pediatr Res; 1984 Nov; 18(11):1136-40. PubMed ID: 6514439 [Abstract] [Full Text] [Related]
25. Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats. Pelham RW, Munsat TL. Brain Res; 1979 Aug 10; 171(3):473-80. PubMed ID: 476482 [Abstract] [Full Text] [Related]
26. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate. Taniguchi T, Tsukahara T, Fujiwara M. Life Sci; 1983 Apr 11; 32(15):1757-63. PubMed ID: 6835022 [Abstract] [Full Text] [Related]
27. Binding of [3H]quinuclidinyl benzilate to regions of rat pituitary and hypothalamus. Hoover DB, Hancock JC, Talley NS. Brain Res Bull; 1981 Mar 11; 6(3):209-11. PubMed ID: 7225899 [Abstract] [Full Text] [Related]
29. Ascorbate induced lipid peroxidation results in loss of receptor binding in tris, but not in phosphate, buffer. Implications for the involvement of metal ions. Abe K, Kogure K, Arai H, Nakano M. Biochem Int; 1985 Sep 11; 11(3):341-8. PubMed ID: 3933512 [Abstract] [Full Text] [Related]
30. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors. Waelbroeck M, Tastenoy M, Camus J, Christophe J. Mol Pharmacol; 1991 Sep 11; 40(3):413-20. PubMed ID: 1896027 [Abstract] [Full Text] [Related]
31. [3H]QNB binding to muscarinic receptors in intact avian salt gland cells. Hootman SR, Ernst SA. Am J Physiol; 1982 Nov 11; 243(5):C254-61. PubMed ID: 7137336 [No Abstract] [Full Text] [Related]
35. Expression of muscarinic cholinergic receptors during T cell maturation in the thymus. Maśliński W, Grabczewska E, Laskowska-Bozek H, Ryzewski J. Eur J Immunol; 1987 Jul 11; 17(7):1059-63. PubMed ID: 3497042 [Abstract] [Full Text] [Related]
36. Binding of [3H]quinuclidinyl benzilate to intestinal mucus. An artifact in identification of epithelial cell muscarinic receptors. Rimele TJ, Gaginella TS. Biochem Pharmacol; 1982 Feb 15; 31(4):515-20. PubMed ID: 7066020 [Abstract] [Full Text] [Related]
37. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane. Vickroy TW, Roeske WR, Yamamura HI. J Pharmacol Exp Ther; 1984 Jun 15; 229(3):747-55. PubMed ID: 6202869 [Abstract] [Full Text] [Related]
38. Methacholine-induced decrease in the cholinergic muscarinic receptor content in the perfused working rat heart. Reinhardt RR, Roskoski R. J Pharmacol Exp Ther; 1983 Jul 15; 226(1):135-9. PubMed ID: 6345753 [Abstract] [Full Text] [Related]